Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco January DIC 600x60px
Collaboration › Details

Heidelberg ImmunoTherapeutics–Akampion: public relations, 201710 service existent by Akampion

 

Period Period 2017-10-26
Organisations Partner, 1st Heidelberg ImmunoTherapeutics GmbH
  Partner, 2nd Akampion
Products Product public relations / investor relations / marcom (services)
  Product 2 LIFE SCIENCES
Persons Person Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland)
  Person 2 Buth, Ines-Regina (akampion 200901 before Micromet Head Investor Relations before Lion Bioscience)
     

Akampion. (10/26/17). "Press Release: Akampion Hosts Expert Panel at BIO-Europe 2017, Co-authors Scientific Article in Human Gene Therapy".

akampion to host expert panel on successful corporate communications at BIO-Europe 2017

We are happy to announce that akampion is a silver sponsor of this year’s BIO-Europe in Berlin and will host an expert panel on successful corporate communications in a changing media and investment world. The discussion will focus on the needs of both healthcare-savvy media / investors and generalists and how companies can address these needs.

Panelists include

Stephen Hansen, Ass. Editor, BioCentury;
Sascha Karberg, Science Writer, Der Tagesspiegel and Transkript;
Eva v. Schaper, Science Writer;
Cormac Sheridan, Science Journalist, BioWorld Today; and
Mike Ward, Global Director of Content, Informa Pharma Insights.

The panel is scheduled on Monday, Nov. 6, 9:00 – 10:30am, City Cube Berlin, Level 3, Room M6. Further information can be found on the BIO-Europe website.

It would be a pleasure to see you at our panel at BIO-Europe. For one-on-one meetings, please feel free to send us a meeting request via BIO-Europe´s online partnering system or by sending an e-mail to info@akampion.com. We look forward to catching up with you in Berlin!

New peer-reviewed article in Human Gene Therapy co-authored by akampion

Moreover, a scientific review written by akampion together with our client Provecs Medical will be published in the December issue of Human Gene Therapy, a peer-reviewed rapid-publication journal covering all aspects of human gene therapy. The article “Immuno-Oncology – the translational runway for gene therapy” appeared online http://online.liebertpub.com/doi/pdfplus/10.1089/hum.2017.145 on October 25, 2017.

Further expanding client roster

In the last months, we have also further expanded our portfolio by a number of new clients with outstanding products and technologies, e.g. BioNTech AG, Phenex Pharmaceuticals, Heidelberg Immunotherapeutics, and Provecs Medical.

   
Record changed: 2018-07-16

Advertisement

Picture EBD Group Biotech Showcase 2019 BTS San Francisco Partnering 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top